|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
5/14/24 BioMarin Pharmaceutical Inc. 8-K:2 5/9/24 10:143K
5/14/24 Tenaya Therapeutics, Inc. 8-K:2,9 5/13/24 9:284K Donnelley … Solutions/FA
5/14/24 Bolt Biotherapeutics, Inc. 8-K:2,5,9 5/13/24 11:573K Donnelley … Solutions/FA
5/14/24 Kubient, Inc. 8-K/A:2,5,9 5/3/24 12:260K Broadridge Fin’l So… Inc
5/13/24 Vintage Wine Estates, Inc. 8-K:2 5/8/24 8:174K Donnelley … Solutions/FA
5/10/24 Nxu, Inc. 8-K:2,7,9 5/8/24 11:210K Securex Filings/FA
5/9/24 Vacasa, Inc. 8-K:2,7,8,9 5/7/24 14:3.5M
5/9/24 Ginkgo Bioworks Holdings, Inc. 8-K:2,9 5/9/24 12:394K Workiva Inc Wde… FA01/FA
5/8/24 STERIS plc 8-K:2,9 5/7/24 12:1.3M
5/8/24 Bionano Genomics, Inc. 8-K:2,9 5/8/24 11:332K
5/8/24 Kubient, Inc. 8-K:2,5,9 5/3/24 12:264K Broadridge Fin’l So… Inc
____________ | ¹ | Filing/Form Type: -K | | 8-K | Current Report — Form 8-K { Item 1: Business & Operations; 2: Financial Info; 3: Securities & Trading; 4: Accountants & Accounting; 5: Governance & Management; 6: Asset-Backed Securities; 7: Disclosures; 8: Events; 9: Financials }. | | /A | Amendment to, or Amended version of, a previous Filing of this Type. |
|